Daiichi Sankyo Japan en las noticias
Innovación y prestación de atención médica global
Tamtam encontró 20 artículos recientes sobre Daiichi Sankyo Japan.
- AstraZeneca/Daiichi Sankyo’s Enhertu® and Datroway® Approved in Japan for First-Line Metastatic Breast Cancer
- Malaysia's IHH's unit loses Tokyo court case against Daiichi Sankyo over Fortis deal
- IHH Healthcare Unit Loses Daiichi Sankyo Court Claim In Japan, Ordered To Bear Litigation Costs
- Daiichi Sankyo bets on new cancer drugs to fuel future growth
- Japan's Daiichi Sankyo unveils five-year business plan focused on oncology innovation
- Japan approve Daiichi Sankyo’s Enhertu as a second-line treatment for gastric cancer
- Nuvation Bio Announces Acquisition of Japan Rights to Safusidenib from Daiichi Sankyo
- Japan expert panel OKs Daiichi Sankyo’s MMR vaccine
- Daiichi Sankyo’s Vanflyta secures Korean approval for FLT3-ITD–positive AML
- 第一三共（東証:4568）はENHERTUの中国承認をオンコロジーの優位性に変えるか？
- Is Daiichi Sankyo (TSE:4568) Turning ENHERTU’s China Approval Into a Durable Oncology Advantage?
- Daiichi Sankyo navigates complexity of success as Enhertu, Datroway push for market dominance
- Is Daiichi Sankyo (TSE:4568) Turning ENHERTU’s China Approval Into a Durable Oncology Moat?
- Japan's Daiichi Sankyo unveils new Toronto headquarters to accelerate investment and innovation in oncology
- Dato-DXd by AstraZeneca and Daiichi Sankyo expected to drive market size of Antibody Drug Conjugates by 2034
- Daiichi Sankyo appoints new head for European research center
- Daiichi Sankyo Company (TSE:4568) Is Due To Pay A Dividend Of ¥39.00
- Daiichi Sankyo and AstraZeneca’s Enhertu gains NMPA approval for HER2 GEJ
- 第一三共(株)【4568】：株価・株式情報
- Daiichi Sankyo Appoints New Leadership at the Daiichi Sankyo Translational Research Center Europe
Artículos recopilados por Tamtam y conservados cuando tratan sobre la empresa, del más reciente al más antiguo. Cada uno enlaza con su fuente.
¿Vendes a empresas como Daiichi Sankyo Japan?
Tamtam encuentra las empresas que encajan con tu cliente ideal, investiga cada cuenta y te dice a quién contactar y cuándo.
Encontrar empresas similares